• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should We Continue to Use Stress Ulcer Prophylaxis for Critically Ill Patients?

出版信息

Can J Hosp Pharm. 2017 Jul-Aug;70(4):316-319. doi: 10.4212/cjhp.v70i4.1684. Epub 2017 Aug 31.

DOI:10.4212/cjhp.v70i4.1684
PMID:28894319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5587048/
Abstract
摘要

相似文献

1
Should We Continue to Use Stress Ulcer Prophylaxis for Critically Ill Patients?我们是否应该继续对重症患者进行应激性溃疡预防？
Can J Hosp Pharm. 2017 Jul-Aug;70(4):316-319. doi: 10.4212/cjhp.v70i4.1684. Epub 2017 Aug 31.
2
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.危重症患者使用质子泵抑制剂与安慰剂进行应激性溃疡预防（SUP-ICU试验）：一项随机对照试验的研究方案
Trials. 2016 Apr 19;17(1):205. doi: 10.1186/s13063-016-1331-3.
3
Stress ulcer prophylaxis for non-critically ill patients on a teaching service.对教学医院中病情不严重患者的应激性溃疡预防措施。
J Eval Clin Pract. 2007 Oct;13(5):716-21. doi: 10.1111/j.1365-2753.2006.00742.x.
4
Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.危重症患者应激性溃疡预防的药物经济学分析
Pharmacoeconomics. 1996 May;9(5):455-65. doi: 10.2165/00019053-199609050-00008.
5
Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.应激性溃疡预防与安慰剂或不预防成人住院急性病患者的系统评价方案：荟萃分析和试验序贯分析。
Syst Rev. 2017 Jun 24;6(1):118. doi: 10.1186/s13643-017-0509-4.
6
Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.用于危重症患者应激性溃疡预防的质子泵抑制剂
Ann Pharmacother. 2002 Dec;36(12):1929-37. doi: 10.1345/aph.1C151.
7
Cost-Effectiveness of Histamine Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.组胺受体拮抗剂与质子泵抑制剂用于危重症患者应激性溃疡预防的成本效益分析
Pharmacotherapy. 2017 Jan;37(1):43-53. doi: 10.1002/phar.1859. Epub 2016 Dec 20.
8
Inappropriate continuation of stress ulcer prophylactic therapy after discharge.出院后不适当继续进行应激性溃疡预防性治疗。
Ann Pharmacother. 2007 Oct;41(10):1611-6. doi: 10.1345/aph.1K227. Epub 2007 Sep 11.
9
When should stress ulcer prophylaxis be used in the ICU?在重症监护病房（ICU）中，应激性溃疡预防措施应在何时使用？
Curr Opin Crit Care. 2009 Apr;15(2):139-43. doi: 10.1097/MCC.0b013e32832978e0.
10
Stress Ulcer Prophylaxis.应激性溃疡预防
Crit Care Med. 2016 Jul;44(7):1395-405. doi: 10.1097/CCM.0000000000001872.

引用本文的文献

1
[Not Available].[无可用内容]
Can J Hosp Pharm. 2019 Nov-Dec;72(6):419-420. Epub 2019 Dec 1.
2
Don't Stress about Ulcer Prophylaxis.别为溃疡预防而焦虑。
Can J Hosp Pharm. 2019 Nov-Dec;72(6):417-418. Epub 2019 Dec 1.
3
[Not Available].[无可用内容]。
Can J Hosp Pharm. 2017 Jul-Aug;70(4):261-262. Epub 2017 Aug 31.
4
Evidence-Based Pharmacy Practice?循证药学实践？
Can J Hosp Pharm. 2017 Jul-Aug;70(4):259-260. doi: 10.4212/cjhp.v70i4.1673. Epub 2017 Aug 31.

本文引用的文献

1
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动：脓毒症与脓毒性休克管理国际指南：2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
2
Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study.泮托拉唑或安慰剂用于应激性溃疡预防（POP-UP）：随机双盲探索性研究
Crit Care Med. 2016 Oct;44(10):1842-50. doi: 10.1097/CCM.0000000000001819.
3
Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.质子泵抑制剂用于危重症患者应激性溃疡预防的疗效与安全性：一项随机试验的系统评价和荟萃分析
Crit Care. 2016 May 4;20(1):120. doi: 10.1186/s13054-016-1305-6.
4
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.危重症患者使用质子泵抑制剂与安慰剂进行应激性溃疡预防（SUP-ICU试验）：一项随机对照试验的研究方案
Trials. 2016 Apr 19;17(1):205. doi: 10.1186/s13063-016-1331-3.
5
Stress ulcer prophylaxis in the intensive care unit.重症监护病房的应激性溃疡预防。
Curr Opin Crit Care. 2016 Apr;22(2):186-90. doi: 10.1097/MCC.0000000000000290.
6
Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis.重症监护病房艰难梭菌感染的患病率及临床结局：一项系统评价与Meta分析
Open Forum Infect Dis. 2015 Dec 1;3(1):ofv186. doi: 10.1093/ofid/ofv186. eCollection 2016 Jan.
7
Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States.美国严重脓毒症患者对重组人活化蛋白C（drotrecogin alfa）的使用与停用情况。
J Crit Care. 2016 Apr;32:114-9. doi: 10.1016/j.jcrc.2015.12.007. Epub 2015 Dec 11.
8
Towards understanding the de-adoption of low-value clinical practices: a scoping review.关于理解低价值临床实践的弃用：一项范围综述
BMC Med. 2015 Oct 6;13:255. doi: 10.1186/s12916-015-0488-z.
9
Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.门诊质子泵抑制剂治疗与社区获得性肺炎风险：一项系统评价和荟萃分析。
PLoS One. 2015 Jun 4;10(6):e0128004. doi: 10.1371/journal.pone.0128004. eCollection 2015.
10
"Entrenched practices and other biases": unpacking the historical, economic, professional, and social resistance to de-implementation.“根深蒂固的做法及其他偏见”：剖析对废除（旧有做法）的历史、经济、专业及社会阻力。
Implement Sci. 2015 Feb 13;10:24. doi: 10.1186/s13012-015-0211-7.